Literature DB >> 25677377

Cannabis legalization with strict regulation, the overall superior policy option for public health.

J Rehm1,2,3,4,5, B Fischer1,4,6.   

Abstract

Cannabis is the most prevalently used drug globally, with many jurisdictions considering varying reform options to current policies to deal with this substance and associated harm. Three policy options are available: prohibition, decriminalization, and legalization, with prohibition currently the dominant model globally. This contribution gives reasons why legalization with strict regulation should be considered superior to other options with respect to public health in high income countries in North America.
© 2015 ASCPT.

Mesh：

Year:  2015        PMID： 25677377     DOI： 10.1002/cpt.93

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  15 in total

1.  Cannabis use, legalization and youth health.

Authors:  Benedikt Fischer; Jürgen Rehm
Journal:  CMAJ       Date:  2017-07-24       Impact factor: 8.262

Review 2.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.

Authors:  Benedikt Fischer; Cayley Russell; Pamela Sabioni; Wim van den Brink; Bernard Le Foll; Wayne Hall; Jürgen Rehm; Robin Room
Journal:  Am J Public Health       Date:  2017-06-23       Impact factor: 9.308

3.  Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.

Authors:  Benedikt Fischer; Cayley Russell; Jürgen Rehm; Pamela Leece
Journal:  J Public Health (Oxf)       Date:  2019-06-01       Impact factor: 2.341

4.  Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.

Authors:  Didier Jutras-Aswad; Bernard Le Foll; Julie Bruneau; T Cameron Wild; Evan Wood; Benedikt Fischer
Journal:  Can J Psychiatry       Date:  2018-07-22       Impact factor: 4.356

5.  Fischer et al. Respond.

Authors:  Benedikt Fischer; Wim van den Brink; Wayne Hall; Bernard LeFoll; Jürgen Rehm; Robin Room
Journal:  Am J Public Health       Date:  2017-12       Impact factor: 9.308

6.  Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013.

Authors:  Deborah S Hasin; Tulshi D Saha; Bradley T Kerridge; Risë B Goldstein; S Patricia Chou; Haitao Zhang; Jeesun Jung; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Bridget F Grant
Journal:  JAMA Psychiatry       Date:  2015-12       Impact factor: 21.596

7.  Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey.

Authors:  Des Crowley; Claire Collins; Ide Delargy; Eamon Laird; Marie Claire Van Hout
Journal:  Harm Reduct J       Date:  2017-01-13

8.  Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy.

Authors:  Lynn T Kozlowski
Journal:  Tob Control       Date:  2016-06-29       Impact factor: 7.552

Review 9.  The importance of psychology for shaping legal cannabis regulation.

Authors:  Jacob T Borodovsky; Michael J Sofis; Richard A Grucza; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2020-05-21       Impact factor: 3.157

10.  A Public Health Framework for Legalized Retail Marijuana Based on the US Experience: Avoiding a New Tobacco Industry.

Authors:  Rachel Ann Barry; Stanton Glantz
Journal:  PLoS Med       Date:  2016-09-27       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.